Markets

Insider Trading

Hedge Funds

Retirement

Opinion

10 Best Stocks to Buy According to Billionaire Dan Loeb

In this article, we will discuss the 10 Best Stocks to Buy According to Billionaire Dan Loeb. You can skip our detailed analysis of Third Point’s strategy and Daniel Loeb’s background and go directly to the 5 Best Stocks to Buy According to Billionaire Dan Loeb.

Daniel Loeb is the founder and CEO of Third Point. He graduated from the University of Columbia with a degree in economics in 1983. Soon after his graduation, he started his career in the investment sector by working at Warburg Pincus, a private equity firm. Over the course of his successful career, Daniel served on boards of several publicly traded companies, including Massey Energy, Ligand Pharmaceuticals, and Sotheby’s. On October 2020, he was awarded the Alexander Hamilton Award for his philanthropic service by the Manhattan Institute.

Third Point is a hedge fund based out of New York, which was launched in 1995 by Daniel Loeb. The fund invests in equity as well as fixed-income markets and invests in value stocks with a long-term view to generate outsized returns for its investors. At the end of Q2 2022, Third Point’s investment in the equity market amounted to over $4.2 billion. The firm holds a concentrated portfolio with PG&E Corporation (NYSE:PCG) as its biggest holding.

Our Methodology

We picked the top 10 stocks from Third Point’s portfolio as of Q2 2022.

10. Cenovus Energy Inc. (NYSE:CV­E)

Third Point Stake: $138,298,000

Percentage of Third Point’s Portfolio: 3.27%

Number of Hedge Fund Holders: 42

Cenovus Energy Inc. (NYSE:CVE) is an oil company engaging in the development of its oil assets. Moreover, the firm produces conventional crude oil, natural gas liquids, and natural gas. Third Point continued to add onto its investment in Cenovus Energy Inc. (NYSE:CVE), as it increased its stake in the company by 264% during the second quarter. The total investment value of the fund in Cenovus Energy Inc. (NYSE:CVE) amounted to approximately $138 million at the end of Q2 2022.

On October 14, 2022, Jason Bouvier, an analyst at Scotiabank, trimmed his price target to C$33 while maintaining an Outperform rating on the company’s shares. Cenovus Energy Inc. (NYSE:CVE) has outperformed the market in 2022 and is up 48.7% YTD.

L1 Capital mentioned the firm in its Q2 2022 investor letter, outlining that:

MEG Energy and Cenovus Energy Inc. (NYSE:CVE): We continue to remain positive on the outlook for Energy. While a potential U.S. recession would result in softer oil demand, we believe this would be more than outweighed by China re-opening over the coming year (which would see a major lift in car and air traffic). Oil supply continues to remain constrained with sustained declines in global inventories and OPEC+ remains unable to grow production significantly. With the sell-off in energy stocks, MEG and Cenovus are currently generating more than 20% of their market cap in cash flow with large dividends and share buybacks to come.

Cenovus Energy (Long +14%) shares rallied driven by continued strong free cash flow generation, as well as being positioned to benefit from strong refining margins and downstream operations. The company recently announced a significant increase in dividends, which gives us greater confidence on the potential for a 100% return of free cash flow generation via dividends and buybacks from early CY23. Given the long-life nature of its oil sand assets and its low cost of production, we estimate the company is free cash flow break-even at an oil price of ~US$40/bbl. At present, oil prices are more than double this break-even point, implying considerable upside to consensus cash flow estimates (if prices remain near current levels). There are also additional value realisation catalysts with the company continuing to progress the de-gearing of its balance sheet via organic cash generation and asset sales.

At the end of Q2 2022, Soroban Capital Partners remained the leading stakeholder of the company, with a holding of 50,338,822. As per Insider’s Monkey database, 42 hedge funds owned stakes in Cenovus Energy Inc. (NYSE:CVE) at the end of the second quarter.

In addition to Cenovus Energy Inc. (NYSE:CVE), Third Point had investments in UnitedHealth Group Incorporated (NYSE:UNH), Danaher Corporation (NYSE:DHR), and PG&E Corporation (NYSE:PCG).

9. CSX Corporation (NASDAQ:CSX)

Third Point Stake: $144,283,000

Percentage of Third Point’s Portfolio: 3.41%

Number of Hedge Fund Holders: 63

CSX Corporation (NASDAQ:CSX) is a US-based holding corporation having holdings in the rail transportation and real estate sectors. Dan Loeb reduced his exposure to the firm by 33% during the second quarter. The fund’s investment in CSX Corporation (NASDAQ:CSX) at the end of the Q2 2022 amounted to approximately $144 million.

On September 30, 2022, Brandon Oglenski, an analyst at Barclays, reduced his price target on CSX Corporation (NASDAQ:CSX) to $35. Although the analyst has an Overweight rating on the shares, he believes that margins in the railroad sector will continue to face pressure in the short term due to volume decline and labor issues.

Clearbridge Investments mentioned CSX Corporation (NYSE:CSX) in their Q4 2021 investor letter. This is what they had to say:

On a regional basis, the U.S. and Canada was the top contributor to quarterly performance, of which U.S. rail operators CSX (NYSE:CSX) was among the lead performers. CSX (NYSE:CSX) is one of five leading North American rail companies, with over 21,000 miles of rail, covering 23 states and 40+ ports. CSX (NYSE:CSX) is engaged in the transportation of rail freight in the Southeast, East, and Midwest via interchange with other rail carriers, to and from the rest of the U.S. and Canada. CSX (NYSE:CSX) performed well during the quarter after the company beats market expectations on its third-quarter results. The beats were largely driven by strong pricing, which could be hitting record highs, and healthy commodity/coal volume driven by the current energy crisis.

As per Insider’s Monkey database, 63 hedge funds owned stakes in Cheniere Energy, Inc. (NYSE:LNG) at the end of the June quarter.  Soroban Capital Partners was the most bullish fund on the company’s stock, with a total holding of 52,600,295.

8. Colgate-Palmolive Company (NYSE:CL)

Third Point Stake: $159,078,000

Percentage of Third Point’s Portfolio: 3.76%

Number of Hedge Fund Holders: 55

Colgate-Palmolive Company (NYSE:CL) has developed to become a significant worldwide consumer goods company since its establishment in 1806. Colgate-Palmolive Company (NYSE:CL) was a new addition to the fund’s portfolio during the second quarter as Dan Loeb purchased 1,985,000 shares of the company.

On October 14, 2022, Peter Grom, an analyst at UBS, reduced his price target on the company to $80 while maintaining a Buy rating on the stock. The analyst believes that Colgate-Palmolive Company (NYSE:CL) has a strong history of surviving in all business cycles and will continue to do well, but the foreign exchange impact due to the appreciation of the US dollar will have an adverse impact on the company.

In its Q2 2022 investor letter, First Eagle Investments Global Fund mentioned Colgate-Palmolive Company (NYSE:CL) and explained its insights for the company. Here is what the fund said:

Shares of consumer staples giant Colgate-Palmolive have performed well as investors rotated into more recessionary-resilient defensive stocks amid the broader selloff during the second quarter. The company raised revenue guidance for 2022 but lowered its margin outlook because of higher costs for raw materials, packaging and logistics; we believe that the company’s size and market share provide it with options to mitigate the inflation challenges it faces. We continue to like Colgate- Palmolive’s dividend and previously announced $5 billion stock buyback program.

7. DuPont de Nemours, Inc. (NYSE:DD)

Third Point Stake: $171,186,000

Percentage of Third Point’s Portfolio: 4.05%

Number of Hedge Fund Holders: 44

DuPont de Nemours, Inc. (NYSE:DD) is a multinational specialty chemicals firm that was established in 2019. Third Point decreased its stake in the company during the second quarter as the fund sold 9% of its stake. The firm’s investment value at the end of Q2 2022 amounts to approximately $171 million.

On October 10, 2022, P.J. Juvekar, an analyst at Citi, made a downward revision to his price target on DuPont de Nemours, Inc. (NYSE:DD). The analyst now has a price target of $67 on the company’s shares. He believes that chemical companies will not thrive at least till spring next year as global economies face a recession and the spending in the housing and construction sector slows down.

Here is what Rhizome Partners has to say about DuPont de Nemours, Inc. (NYSE:DD) in its Q1 2021 investor letter:

We have written extensively about the anticipated DuPont’s Reverse Morris Trust merger with International Flavors and Fragrances (IFF) in January of 2021. During the quarter, DuPont shares traded up significantly in anticipation of the deal. We tendered about 40% of our DuPont shares for IFF and received about half of the allocation due to pro-ration. Investors are finally starting to appreciate DuPont’s effort to cut costs, streamline operations, and spin off companies into pure-play companies that trade at higher multiples. We are still getting used to the higher multiples that investors will pay for larger market cap and pure play companies such as DuPont.

6. EQT Corporation (NYSE:EQT)

Third Point Stake: $258,860,000

Percentage of Third Point’s Portfolio: 6.12%

Number of Hedge Fund Holders: 52

EQT Corporation (NYSE:EQT) is a producer of natural operating in the United States. Dan Loeb reduced his stake in EQT Corporation (NYSE:EQT) by 16% during Q2 2022, and at the end of the quarter, the fund held 7,525,000 shares of the company.

On September 19, 2022, Phillip Jungwirth, an analyst at BMO Capital, upgraded his rating on EQT Corporation (NYSE:EQT) to Outperform. The analyst has a price target of $65 on the company’s stock and believes that the management of the company has taken effective cost management measures. Along with that, the analyst argues that gas prices are expected to remain elevated in the future, which will lead to better performance for the company in 2023.

In its Q2 2022 investor letter, ClearBridge Investments, an asset management firm, highlighted a few stocks, and Marathon Petroleum Corporation (NYSE:MPC) was one of them. Here is what the fund said:

We initiated a position in EQT (NYSE:EQT), the largest natural gas producer in the U.S., which possesses high-quality acreage within the Marcellus Shale basin. EQT has benefited from tight supply and demand dynamics as cleaner-burning natural gas takes global share from coal and exports to Europe and Asia provide an avenue of demand growth. Longer-term contracts enhance EQT’s earnings visibility as Europe eliminates its dependence on Russian gas.

Click to continue reading and see 5 Best Stocks to Buy According to Billionaire Dan Loeb.

Suggested articles:

Disclosure: None. 10 Best Stocks to Buy According to Billionaire Dan Loeb is originally published on Insider Monkey.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!